Fetal Bovine Serum (FBS) Gamma-Irradiated
Gamma-irradiated fetal bovine serum (FBS) is a blood fraction derived from bovine fetuses, processed with gamma radiation to inactivate potential viral contaminants. It is used as a cell culture supplement in gene therapy research and diagnostic applications. This product falls under tariff item 3002.12.00 as a modified animal blood fraction prepared for therapeutic or prophylactic uses.
Import Duty Rates by Country of Origin
| Origin Country | MFN Tariff | Surtaxes | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇺🇸United States | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If the product is presented as an immunological product rather than a general blood fraction
Subheading 3002.13 covers immunological products, which may apply if the FBS is specifically processed for immune-related applications.
If the product is not prepared for therapeutic or prophylactic uses
Animal blood not prepared for therapeutic or prophylactic uses falls under Chapter 5, not Chapter 30.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right tariff item — and can price the duty on it in the same conversation.
Import Tips & Compliance
• Ensure the gamma irradiation certificate is included with the commercial invoice to demonstrate the sterilization process
• Verify that the product is not intended for food or beverage use, as those are excluded from Chapter 30
• Check if a veterinary permit is required from the Canadian Food Inspection Agency (CFIA) for animal-derived biological materials
Related Products under Tariff item 3002.12.00
Anti-Rh(D) Immunoglobulin Injection
Anti-Rh(D) immunoglobulin injection is a blood fraction containing antibodies against the Rh(D) antigen, derived from human plasma. It is administered prophylactically to prevent hemolytic disease of the newborn in Rh-negative mothers. This product is classified under tariff item 3002.12.00 as an antiserum prepared for therapeutic use.
Botulinum Toxin Type A Immune Globulin
Botulinum toxin type A immune globulin is an antitoxin derived from human plasma fractions containing antibodies against botulinum toxin. It is used to treat infant botulism by neutralizing the toxin. This product falls under tariff item 3002.12.00 as an immunological blood fraction for therapeutic neutralization.
Botulism Antitoxin (Trivalent, Equine)
Botulism Antitoxin (Trivalent, Equine) is an antiserum derived from equine plasma containing antibodies that neutralize botulinum neurotoxins A, B, and E. It is used therapeutically for the treatment of botulism poisoning. This product falls under tariff item 3002.12.00 as an antiserum prepared for therapeutic uses.
Cryoprecipitated Antihemophilic Factor from Human Plasma
Cryoprecipitated Antihemophilic Factor from Human Plasma is a human plasma fraction rich in factor VIII, fibrinogen, and von Willebrand factor. It is prepared by thawing frozen plasma at 1-6°C and used to treat hemophilia A and fibrinogen deficiencies. This product falls under tariff item 3002.12.00 as a blood fraction for therapeutic use.
Cytomegalovirus (CMV) Hyperimmune Globulin
Cytomegalovirus (CMV) hyperimmune globulin is a plasma fraction enriched with CMV-specific antibodies, used to prevent CMV infection in transplant patients. It is prepared from pooled human plasma of donors with high antibody titers. This product is classified under tariff item 3002.12.00 as a blood fraction prepared for prophylactic use.
Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV)
Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV) is a purified immunoglobulin fraction derived from human plasma of donors with high CMV antibody titers. It is used prophylactically to prevent CMV infection in transplant patients. This product falls under tariff item 3002.12.00 as a blood fraction prepared for therapeutic or prophylactic uses.